FDAFDA · Food and drugs·Recall number D-0597-2018
Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01
Published March 21, 2018 · Recall initiated: February 7, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HYDROMORPHONE HYDROCHLORIDE
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot 71330DD EXP. 11/1/2018.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.